Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
Adverse Effects of Proton Pump Inhibitor Use in Patients with Cardiovascular Disease: Pharmacovigilance Attention Needed!! Dr. Kamal Kant Kohli8 Sept 2023 11:30 AM ISTSince the introduction of proton pump inhibitors (PPIs), they have steadily become the mainstay in treating acid-related disorders. The adoption of...
How to quickly transport organs for transplantation by Air: Dr P.K.Verma Dr. P.K.Verma13 July 2023 9:30 AM ISTOrgan transplantation is a surgical procedure in which tissue or an organ is transferred from one area of a person's body to another area, or from...
Glimepiride Stands Tall on Cardiovascular Safety Again: Latest Update Dr. Prem Aggarwal9 Jun 2023 11:36 AM ISTThe epidemiologic link between diabetes & heart failure is well established, with a burden of heart failure among 22% of patients with diabetes...
Colchicine's beneficial in post AF ablation pericarditis? An elusive question in search of an answer dr. Abhimanyu Uppal27 April 2023 11:00 AM ISTAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. Catheter ablation is now a well-established...
Torsemide and furosemide show no significant difference in all-cause mortality in HF patients: JAMA Dr. Mahalakshmi Sivashankaran28 March 2023 11:00 AM ISTUSA: A recent Clinical Trial called TRANSFORM-HF, published in JAMA, has found that torsemide and furosemide, two commonly used loop diuretics for...
Management of CVD in Indian Settings and Scope of Amlodipine and Atenolol Fixed-Dose Combination-Review Dr. Prem Aggarwal6 March 2023 11:58 AM ISTCardiovascular diseases (CVDs) have become the leading cause of mortality in India. With one-quarter of all deaths being associated with CVDs,...
Amlodipine as First-line Antihypertensive-Review of Indian Evidence Dr. Prem Aggarwal30 Jan 2023 12:00 PM ISTHypertension, often referred to as "the silent killer," is a significant global public health burden due to its risk for myocardial infarction (MI)...
Managing Angina: How 50 years Old Propranolol Stands Out! Dr. Prem Aggarwal12 Jan 2023 11:30 AM ISTIschaemic heart disease is a leading cause of mortality and disability worldwide, with angina being the most prevalent and worrisome clinical symptom....
RSSDI Releases Guidelines for Management of Hypertension in Diabetes Mellitus 2022 Dr. Kamal Kant Kohli21 Dec 2022 12:45 PM ISTCatering to the pressing need to outline an evidence and experience based comprehensive treatment yardstick, the first-ever Indian guideline for the...
Battling Heart Failure- Decoding the Scope of Metoprolol Dr. Prem Aggarwal16 Dec 2022 12:08 PM IST#inside_post_content_ad_1_before, #inside_post_content_ad_2_before, #inside_post_content_ad_3_before, #inside_post_content_ad_2_before{min-height: 0px...
